Neurocrine Biosciences Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 30 trades in Neurocrine Biosciences Inc (NASDAQ: NBIX) since 2018, across 5 members, worth an estimated $802.01K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 14 buys against 16 sells, a modestly sell-led skew, with Democratic members responsible for 23% of the trades and Republican members 77%. The most recent disclosure shown was filed August 2025, and Lisa Mcclain has filed the most NBIX transactions among those shown, with 2. One notable disclosed move was a purchase by Lisa Mcclain on June 11, 2025, up 33.0% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Neurocrine Biosciences Inc (NBIX) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Neurocrine Biosciences congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Lisa Mcclain House | Aug 13, 2025 | Jun 17, 2025 | 57 days | SELL |  $1,001 - $15,000 | +32.21% | |
Lisa Mcclain House | Aug 13, 2025 | Jun 11, 2025 | 63 days | BUY | $1,001 - $15,000 | +32.97% |
Neurocrine Biosciences (NBIX) congressional trading FAQ
Can members of Congress legally trade Neurocrine Biosciences (NBIX) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Neurocrine Biosciences (NBIX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Neurocrine Biosciences (NBIX) trades public?
Yes. Every congressional trade in Neurocrine Biosciences (NBIX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Neurocrine Biosciences (NBIX)?
Members of Congress have disclosed 30 trades in Neurocrine Biosciences (NBIX) worth $802.01K across 5 members, according to public STOCK Act filings.
Which members of Congress have traded Neurocrine Biosciences (NBIX)?
Recent and active filers of Neurocrine Biosciences (NBIX) disclosures include Lisa Mcclain. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Neurocrine Biosciences (NBIX) more?
Across disclosed Neurocrine Biosciences (NBIX) trades, 23% were by Democrats and 77% by Republicans, led by Republicans (77%).
What is the most recent congressional Neurocrine Biosciences (NBIX) trade?
The most recent disclosed Neurocrine Biosciences (NBIX) trade was a purchase by Lisa Mcclain, filed Aug 12, 2025.
Browse all stocks Congress tradesCongressional trading overviewNeurocrine Biosciences (NBIX) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.